Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center
CMI Communications · 2024
DOI: 10.1016/j.cmicom.2024.100005 ↗Kurz gefasst
Fachartikel in der Zeitschrift CMI Communications, 2024. Verfasst von Erol Orel und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculté de Médecine, Université de Genève, Swiss National Science Foundation.
Abstract (Originalsprache)
Introduction
We aimed to compare the severity of the Delta variant and the Omicron sub-lineages BA.1, BA.2 and BA.4/5 in patients hospitalized directly because of COVID-19 at the largest university hospital in Switzerland.
Methods
We conducted a retrospective monocentre cohort study including patients recorded in the COVID-19 Hospital Based Surveillance system hospitalized because of a Delta or different Omicron sub-lineages infection from July 1, 2021 to September 28, 2022. Multinomial regression models with propensity score weighting to balance for confounding were used to assess the clinical severity of each variant. Additional time-to-event analyses were performed using Kaplan-Meier methodology.
Results
The minimum number of eligible patients before variable imputation amounted to 1,475 (320, 340, 164 and 299 infected by Delta, Omicron BA.1, BA.2 and BA.4/5 respectively). Over time, the hospitalized populations became older and more frequently vaccinated (p < 0.001). No statistical significance was observed in the clinical severity among the three Omicron sub-lineages. In comparison to being infected with Delta, being infected with all tested Omicron lineages was associated with a decreased probability of severe or critical disease. The odds ratios for severe or critical disease, respectively, were as follows: (OR 0.33 (95 % CI 0.13; 0.83, p = 0.005) and 0.27 (95 % CI 0.10; 0.75, p < 0.001) for Omicron BA.1); (0.37 (95 % CI 0.14; 0.97, p = 0.020) and 0.23 (95 % CI 0.08; 0.70, p < 0.001) for Omicron BA.2); and (0.33 (95 % CI 0.13; 0.83, p = 0.005) and 0.12 (95 % CI 0.03; 0.41, p < 0.001) for Omicron BA.4/5).
Discussion
Our study confirmed the decreased severity of Omicron in hospitalized patients and highlights the burden of COVID-19 for older adults who require hospitalization even when presenting with mild disease, mainly because of a decompensation of an underlying disease.
Förderung
- Faculté de Médecine, Université de Genève
- Swiss National Science Foundation
Zitieren
APA
Orel, E., Sobel, J., Zanella, M., Iten, A., Kaiser, L., Keiser, O., & Vetter, P. (2024). Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center. CMI Communications. https://doi.org/10.1016/j.cmicom.2024.100005
Vancouver
Orel E, Sobel J, Zanella M, Iten A, Kaiser L, Keiser O, et al. Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center. CMI Communications. 2024. doi:10.1016/j.cmicom.2024.100005
BibTeX
@article{Orel2024,
author = {Orel, Erol and Sobel, Jonathan and Zanella, Marie-Céline and Iten, Anne and Kaiser, Laurent and Keiser, Olivia and Vetter, Pauline},
title = {Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center},
journal = {CMI Communications},
year = {2024},
doi = {10.1016/j.cmicom.2024.100005}
}
EUVIMED